While supporting the use of these technologies, IDFA and other associations representing a broad cross section of the U.S. food and agriculture value chain cautioned APHIS that the proposed exemptions would eliminate any APHIS regulatory oversight or notification of the movement of certain gene edited crops. The comments also raised concerns that the lack of transparency could create asymmetrical trade approvals.
“Looking toward the future of biotechnology, dairy companies understand that consumers want to know more about what is in their food, not less,” said Danielle Quist, IDFA senior director, regulatory affairs and counsel. “As the use of gene editing and other new biotechnologies becomes more prevalent, it is important that consumers have confidence in APHIS and its regulation of new biotechnologies.”